Together, these recent results suggest that a promising strategy for an effective malaria vaccine may involve multi-antigen and/or multi-stage (e.g. PfRH5/CSP-based) vaccine combination that targets both pre-erythrocytic and blood-stages to prevent parasite infection and subsequent development in human host, respectively. Here, DNAJC5 is linked to malaria.